tiprankstipranks
Advertisement
Advertisement

RGNX Stock Latest News

Video: Alibaba slips as shares offered to support AI investment
The FlyVideo: Alibaba slips as shares offered to support AI investment
2h ago
NVT
PDD
Morning Movers: Regenxbio sinks following clinical hold on RGX-121
PremiumThe Fly
Morning Movers: Regenxbio sinks following clinical hold on RGX-121
2h ago
GGR
PDD
Regenxbio to resume trading at 7:25 am ET
PremiumThe Fly
Regenxbio to resume trading at 7:25 am ET
4h ago
RGNX
Regenxbio reports FDA placed clinical hold on RGX-121
PremiumThe Fly
Regenxbio reports FDA placed clinical hold on RGX-121
4h ago
RGNX
Regenxbio price target lowered to $23 from $26 at H.C. Wainwright
PremiumThe Fly
Regenxbio price target lowered to $23 from $26 at H.C. Wainwright
14d ago
RGNX
Regenxbio price target raised to $18 from $16 at Morgan Stanley
PremiumThe FlyRegenxbio price target raised to $18 from $16 at Morgan Stanley
17d ago
RGNX
Regenxbio downgraded to Equal Weight from Overweight at Barclays
Premium
The Fly
Regenxbio downgraded to Equal Weight from Overweight at Barclays
17d ago
RGNX
Regenxbio reports Q2 EPS 43c vs. ($1.38) last year
Premium
The Fly
Regenxbio reports Q2 EPS 43c vs. ($1.38) last year
18d ago
RGNX
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
20d ago
RGNX
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
RegenXBio Inc. (RGNX) Q2 Earnings Cheat Sheet
21d ago
RGNX
RegenXBio Raises Capital Through Public Equity Offering
PremiumCompany Announcements
RegenXBio Raises Capital Through Public Equity Offering
1M ago
8K
RGNX
Regenxbio presents long-term data for surabgene lomparvovec
PremiumThe Fly
Regenxbio presents long-term data for surabgene lomparvovec
1M ago
RGNX
Midday Fly By: Netflix forecast fuels fears, SpaceX tumbles after scrubbing test
PremiumThe FlyMidday Fly By: Netflix forecast fuels fears, SpaceX tumbles after scrubbing test
1M ago
AA
BP
Regenxbio 10M share Spot Secondary priced at $9.00
Premium
The Fly
Regenxbio 10M share Spot Secondary priced at $9.00
1M ago
RGNX
Regenxbio announces $100M common stock offering
Premium
The Fly
Regenxbio announces $100M common stock offering
1M ago
RGNX
RegenXBio: Advancing Gene Therapy Pipeline and De-Risking Milestones Support Buy Rating and Unchanged $26 Price Target
PremiumRatings
RegenXBio: Advancing Gene Therapy Pipeline and De-Risking Milestones Support Buy Rating and Unchanged $26 Price Target
2M ago
RGNX
Regenxbio Advances Diabetic Retinopathy Gene Therapy Trial
PremiumCompany Announcements
Regenxbio Advances Diabetic Retinopathy Gene Therapy Trial
2M ago
8K
RGNX
Regenxbio says first patient dosed in Phase IIb/III NAAVIGATE trial
PremiumThe Fly
Regenxbio says first patient dosed in Phase IIb/III NAAVIGATE trial
2M ago
ABBV
RGNX
RegenXBio: Advancing Late-Stage RGX-202 and Navsunli Programs Underpin Buy Rating, $16 Price Target Maintained
PremiumRatings
RegenXBio: Advancing Late-Stage RGX-202 and Navsunli Programs Underpin Buy Rating, $16 Price Target Maintained
2M ago
RGNX
Regenxbio completes dosing in confirmatory study of RGX-202
PremiumThe FlyRegenxbio completes dosing in confirmatory study of RGX-202
2M ago
RGNX
Regenxbio price target raised to $32 from $27 at Baird
Premium
The Fly
Regenxbio price target raised to $32 from $27 at Baird
2M ago
RGNX
H.C. Wainwright notes Regenxbio doesn’t need more studies for BLA resubmission
Premium
The Fly
H.C. Wainwright notes Regenxbio doesn’t need more studies for BLA resubmission
2M ago
RGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >